BMS-986458 features three stereocenters, one of which epimerizes easily, Mortensen said. The drug candidate, which would be ...

Theratechnologies Inc.’s THTX share price has surged by 28.57%, which has investors questioning if this is right time to sell ...

Viking Therapeutics, Inc. ("Viking") , a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced the completion of ...

People who take weight-loss drugs based on GLP-1 receptor agonists seem to have reduced risk for a litany of diseases, including Alzheimer's, but an increase in some other conditions like kidney ...

When choosing a supplement, look for independently tested products and consult ... that may help treat and manage MASLD and metabolic dysfunction-associated steatohepatitis (MASH), formerly known as ...

Research shows weight loss surgery can help reduce the risk of severe liver problems for some patients with MASH.

"I said 'genetics are crazy' because our baby looks more like my mom than I do," the 33-year-old said. "It's just wild to see how traits can skip a generation. I think it's so fascinating and ...

Fans shared confusion in the replies, with reactions like, "Wow she looks completely like a different person," and "omg i didn’t recognize her." Others commented on her resemblance to her mother ...

Resmetirom offers a targeted approach to metabolic dysfunction–associated steatohepatitis (MASH) for use alongside lifestyle ...